wrap-up deliv steadi
net dbt
top-lin larg expect w/ bonu larg opm beat
report organ sale growth yoy inclus sell day
report revenu roughli in-lin our/street est
key sub-seg in-lin expect refer lab organ
rapid assay although instrument revenu touch light off-set
stronger lpd segment big surpris quarter margin well ahead
gm opm lead beat bottom line see first look
addit detail result
biz steadi goe fy outlook unchang
hand minor abnorm quarter soft quarter sedivu
placement given increas emphasi catalyst tough comp pull-
forward uk consum due brexit stock major result
in-lin long-term model core busi continu chug along
also note chang fy outlook top-lin rais
ep guid mostli reflect margin beat tie delay
 invest impli signific chang trajectori rest
year view result solid start year
updat estim rais po reiter buy
given favor reaction result without top-lin beat rais
organ revenu guid believ expect appropri reset
somewhat mix reaction print make tweak
model estim larg unchang beyond flow-through opm
beat although believ setup favor given increment easier
comp sell day reiter buy rate rais po
base ep vs prior look forward next catalyst
compani annual analyst day august
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
lead provid diagnost
inform technolog product servic
pet product anim health water qualiti
milk safeti human point-of-car diagnost
market leader thank rich new
product cycl posit trend companion
anim health market compani look well
posit continu strong growth trajectori
share trade premium peer
compani histor trend believ
premium well-deserv compani long-
term runway continu out-perform
driven new product launch industry-
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
share trade signific premium broader anim health peer
group histor level howev given mani posit secular product
tailwind compani current enjoy believ premium valuat justifi
po base ep estim roughli in-lin histor
trend observ high growth life scienc diagnost tool compani
downsid risk po lower spend vet servic event
econom slowdown slower-than-expect uptak new product ou expans
competit lower-than-expect margin expans weather disrupt currenc
michael ryskin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us life scienc diagnost tool anim health coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
